讲师:郑晓晖直播时间:18:30-19:30参考文献 [1] 中国老年医学学会心血管病分会. 高龄老年(≥75岁)急性冠状动脉综合征患者规范化诊疗中国专家共识[J]. 中国循环杂志, 2018, 33(8). [2] Cannon C P, Bhatt D L, Oldgren J, et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation[J]. New England Journal of Medicine, 2017,377(16):1513. [3] Bhatt D L, Bonaca M P, Sameer Bansilal M, et al. Reduction in Ischemic Events with Ticagrelor in Diabetic Patients: From the PEGASUS-TIMI 54 Trial[J]. Journal of the American College of Cardiology, 2016,67(13):2111. [4] Valgimigli M, Bueno H, Byrne R A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European A[J]. European Heart Journal, 2017,39(3):e1. [5] Pascal Vranckx, Marco Valgimigli, Peter Jüni, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018; August 27, 2018. 说明: